Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00516958Phase 2Completed
A Phase 2 trial of MicrocynRX in diabetic foot infection (DFI), sponsored by Sonoma Pharmaceuticals, Inc.. Started May 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00516958.